Bcl2

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 22.03.2022

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

BCL2 (BCL is the acronym for "B-cell lymphoma") is a protein that plays an important role in the regulation of apoptosis (see also BCL6). Some proteins of the BCL family exert their function by regulating the release of cytochrome C from the mitochondrion. This results in apoptosis.

Mutations in BCL family genes can have serious consequences. Therefore, this protein family is also considered a human proto-oncogene (see Oncogenes below).

"Overactivation" of BCL2 leads to proliferation of the tissue and thus to tumor formation. Thus, the chromosomal translocation t(14;18) (q32;q21) in follicular lymphoma leads to overexpression of BCL2.

The detection of BCL2 also plays a role in diffuse large B-cell lymphoma of the leg type (see lymphoma, cutaneous B-cell lymphoma, large B-cell lymphoma of the leg).

LiteratureThis section has been translated automatically.

  1. Hallermann C et al (2004) Molecular cytogenetic analysis of chromosomal breakpoints in the IGH, MYC, BCL6 and MALT1-gene loci in primary cutaneous B-cell-lymphomas.J Invest Dermatol 123: 213-219

Authors

Last updated on: 22.03.2022